{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:03:21Z","timestamp":1783695801807,"version":"3.55.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Cardiometabolic health, Diabetes and Obesity Network"},{"name":"Le Fonds de recherche du Qu\u00e9bec - Sant\u00e9"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Multifactorial chylomicronemia syndrome (MCS) is a severe form of hypertriglyceridemia (hyperTG) associated with an increased risk of acute pancreatitis. However, the risk of acute pancreatitis is very heterogenous in MCS. Previous studies suggested that inflammation might promote disease progression in hyperTG-induced acute pancreatitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine if low-grade inflammation is associated with acute pancreatitis in MCS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study included 102 subjects with MCS for whom high-sensitivity C-reactive protein (hsCRP) concentration was measured at their first visit at the Montreal Clinical Research Institute.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with MCS who had a previous history of acute pancreatitis had a significant higher hsCRP concentration (4.62\u2005mg\/L vs 2.61\u2005mg\/L; P = .003), and high hsCRP concentration (\u2265 3\u2005mg\/L) was independently associated with acute pancreatitis prevalence (P &amp;lt; .05). Up to 64% of the variability in acute pancreatitis prevalence was explained by the maximal triglycerides (TG) concentration, hsCRP concentration, the presence of rare variants in TG-related genes, and fructose intake, based on a stepwise multivariate regression model (P &amp;lt; .0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This retrospective study showed for the first time that hsCRP concentration is strongly associated with acute pancreatitis prevalence in MCS. It also suggests that low-grade inflammation may be a driver of acute pancreatitis in severe hypertriglyceridemia. Prospective studies could help determine the causality of this association and assess whether medication known to reduce low-grade inflammation could help prevent acute pancreatitis in individuals with severe hypertriglyceridemia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae103","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T18:53:24Z","timestamp":1709060004000},"page":"e2255-e2260","source":"Crossref","is-referenced-by-count":5,"title":["High hsCRP Concentration Is Associated With Acute Pancreatitis in Multifactorial Chylomicronemia Syndrome"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6327-7048","authenticated-orcid":false,"given":"Simon-Pierre","family":"Guay","sequence":"first","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]},{"name":"Department of Medicine, Division of Endocrinology, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, Qu\u00e9bec, H3T 1J4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-1275","authenticated-orcid":false,"given":"Martine","family":"Paquette","sequence":"additional","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Blais","sequence":"additional","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"Fortin","sequence":"additional","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9534-1657","authenticated-orcid":false,"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[{"name":"Genetic Dyslipidemias Clinic, Montreal Clinical Research Institute , Montr\u00e9al, Qu\u00e9bec, H2W 1R7 ,","place":["Canada"]},{"name":"Department of Medicine, Divisions of Experimental Medicine and Medical Biochemistry, McGill University , Montr\u00e9al, Qu\u00e9bec, H3A 0G4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"6","key":"2024111804001003300_dgae103-B1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2024111804001003300_dgae103-B2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J Lipid Res"},{"issue":"6","key":"2024111804001003300_dgae103-B3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinternmed.2008.599","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults","volume":"169","author":"Ford","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"2024111804001003300_dgae103-B4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe hypertriglyceridaemia and chylomicronaemia syndrome-causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"issue":"4","key":"2024111804001003300_dgae103-B5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2020","journal-title":"J Intern Med"},{"issue":"1","key":"2024111804001003300_dgae103-B6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European atherosclerosis society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024111804001003300_dgae103-B7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2024111804001003300_dgae103-B8","doi-asserted-by":"crossref","first-page":"e3473","DOI":"10.1210\/clinem\/dgab360","article-title":"Rare variants in triglycerides-related genes increase pancreatitis risk in multifactorial chylomicronemia syndrome","volume":"106","author":"Paquette","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024111804001003300_dgae103-B9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4158\/EP-2018-0599","article-title":"External validation of a predictive model for acute pancreatitis risk in patients with severe hypertriglyceridemia","volume":"25","author":"Morkos","year":"2019","journal-title":"Endocr Pract"},{"issue":"4","key":"2024111804001003300_dgae103-B10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2016.02.019","article-title":"Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system","volume":"10","author":"Rashid","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"19","key":"2024111804001003300_dgae103-B11","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3748\/wjg.v20.i19.5801","article-title":"Acute pancreatitis: the stress factor","volume":"20","author":"Binker","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2024111804001003300_dgae103-B12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2018.294926","article-title":"Low-Grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population","volume":"65","author":"Hansen","year":"2019","journal-title":"Clin Chem"},{"key":"2024111804001003300_dgae103-B13","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.12659\/MSM.915526","article-title":"Low serum ionized calcium, elevated high-sensitivity C-reactive protein, neutrophil-lymphocyte ratio, and Body Mass Index (BMI) are risk factors for severe acute pancreatitis in patients with hypertriglyceridemia pancreatitis","volume":"25","author":"Yu","year":"2019","journal-title":"Med Sci Monit"},{"issue":"1","key":"2024111804001003300_dgae103-B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem"},{"issue":"25","key":"2024111804001003300_dgae103-B15","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"2024111804001003300_dgae103-B16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"6","key":"2024111804001003300_dgae103-B17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3945\/an.115.009415","article-title":"Effect of nutritional status and dietary patterns on human serum C-reactive protein and interleukin-6 concentrations","volume":"6","author":"Smidowicz","year":"2015","journal-title":"Adv Nutr"},{"issue":"1","key":"2024111804001003300_dgae103-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07853890.2017.1325967","article-title":"Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U.S. adults","volume":"50","author":"Mazidi","year":"2018","journal-title":"Ann Med"},{"issue":"2","key":"2024111804001003300_dgae103-B19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ejcn.2011.163","article-title":"Validity and reproducibility of a web-based, self-administered food frequency questionnaire","volume":"66","author":"Labont\u00e9","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"2024111804001003300_dgae103-B20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"8","key":"2024111804001003300_dgae103-B21","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/js.2019-00129","article-title":"Very severe hypertriglyceridemia in a large US county health care system: associated conditions and management","volume":"3","author":"Esparza","year":"2019","journal-title":"J Endocr Soc"},{"issue":"6","key":"2024111804001003300_dgae103-B22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2019.08.002","article-title":"Subsets associated with developing acute pancreatitis in patients with severe hypertriglyceridemia and the severity of pancreatitis","volume":"19","author":"Jo","year":"2019","journal-title":"Pancreatology"},{"key":"2024111804001003300_dgae103-B23","first-page":"2620750","article-title":"Diabetes and younger age are vital and independent risk factors for acute pancreatitis in patients with severe hypertriglyceridemia","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"issue":"2","key":"2024111804001003300_dgae103-B24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOL.0000000000000866","article-title":"Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia","volume":"34","author":"Hang","year":"2023","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"2024111804001003300_dgae103-B25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1053\/j.gastro.2013.01.069","article-title":"Genetic risk factors for pancreatic disorders","volume":"144","author":"Whitcomb","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"2024111804001003300_dgae103-B26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jhh.2010.91","article-title":"The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"25","author":"Lakoski","year":"2011","journal-title":"J Hum Hypertens"},{"key":"2024111804001003300_dgae103-B27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fendo.2018.00556","article-title":"Associations between C-reactive protein, insulin sensitivity, and resting metabolic rate in adults: a mediator analysis","volume":"9","author":"Drabsch","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024111804001003300_dgae103-B28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.118.035107","article-title":"Low-Grade inflammation modifies cardiovascular risk even at very low LDL-C levels: are we aiming for a dual target concept?","volume":"138","author":"Koenig","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"2024111804001003300_dgae103-B29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/2047487319885458","article-title":"Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: implications for an anti-inflammatory treatment target population","volume":"28","author":"Blaum","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"2024111804001003300_dgae103-B30","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.3390\/ijerph192013111","article-title":"The association between high-sensitivity C-reactive protein and metabolic syndrome in an elderly population aged 50 and older in a community receiving primary health care in Taiwan","volume":"19","author":"Shih","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2024111804001003300_dgae103-B31","doi-asserted-by":"crossref","first-page":"8732360","DOI":"10.1155\/2022\/8732360","article-title":"Effect of statins on serum level of hs-CRP and CRP in patients with cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"2022","author":"Kandelouei","year":"2022","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2024111804001003300_dgae103-B32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1758-5996-3-24","article-title":"Short-term effect of fenofibrate on C-reactive protein: a meta-analysis of randomized controlled trial","volume":"3","author":"Ye","year":"2011","journal-title":"Diabetol Metab Syndr"},{"issue":"26","key":"2024111804001003300_dgae103-B33","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"2024111804001003300_dgae103-B34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nutres.2022.02.001","article-title":"Both low-fat and low-carbohydrate diets reduce triglyceride concentration in subjects with multifactorial chylomicronemia syndrome: a randomized crossover study","volume":"101","author":"Fantino","year":"2022","journal-title":"Nutr Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae103\/56911940\/dgae103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/e2255\/60680273\/dgae103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/e2255\/60680273\/dgae103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:00:38Z","timestamp":1731902438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/12\/e2255\/7614750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae103","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,2,27]]}}}